No Data
TENTIAL, ABEJA, and others
Logos HD has introduced a shareholder benefits program. Base Food (2936) has formed a capital and business alliance with the Melco Group, which handles the holding and management of securities. TENTIAL has revised its forecast upwards, with the current fiscal year's operating profit outlook raised to 3.804 billion yen from 3.020 billion yen, accompanied by a stock split of 3 shares for every 1 share and an enhancement of its shareholder benefits program. U&C (3557) has made partial changes to its shareholder benefits program. Medicalnet (3645) has revised its shareholder benefits program. Axel Space has adjusted its earnings forecast, with the current fiscal year’s operating loss projected.
FIXER --- Rebounded, announced earnings forecast for the fiscal year ending August 2026 which had been undisclosed.
The company's stock rebounded following the announcement of its previously undisclosed earnings forecast for the fiscal year ending August 2026, which has been perceived as positive news. The net loss is expected to narrow to 1.566 billion yen (from a net loss of 2.117 billion yen in the previous term) due to the recovery of existing businesses and progress in fixed-cost reductions. The company is currently in a transitional phase aimed at transforming its earnings structure. In its new business segment, the Sovereign AI division, commercialization of 'Sovereign GaiXer' has been completed, and formal orders have begun to be accepted through agency channels.
FIXER: Semiannual Report – Fiscal Year 17 (September 1, 2025 – August 31, 2026)
FIXER: Confirmation letter
The U.S.-Iran peace talks failed to reach an agreement, leading to a subdued market sentiment.
[Emerging Market Individual Stock Strategy] Today's emerging market is expected to remain subdued. On Friday, October 10, the U.S. stock market saw the Dow Jones Industrial Average fall by 269.23 points (-0.56%) to 47,916.57, declining for the first time in three days. While the core Consumer Price Index (CPI) came in below expectations, providing some support for stock prices, a warning from President Trump that he is prepared to resume attacks if negotiations fail led to a rise in crude oil and long-term interest rates, pushing the Dow further down. Meanwhile, Nasdaq remained firm throughout the day, supported by semiconductor stocks.
SNS, LTS, and others
Company 3967 (Eltes) has revised its earnings forecast, with the previous fiscal year's operating profit outlook adjusted to JPY 4.30 billion from JPY 3.80 billion. Company 4076 (CNS) has upwardly revised its forecast, with the current fiscal year's operating profit outlook now at JPY 7.10 billion, up from JPY 6.58 billion, accompanied by an increased dividend; the year-end dividend per share remains unchanged at JPY 55.00. Renascience has announced the results of Phase II clinical trials for RS5614, a PAI-1 inhibitor for systemic sclerosis-associated interstitial lung disease (SSc-ILD). Company 4892 (Cyfuse) is advancing the development of new treatments in the dental field.